AMRX Total Liabilities - Amneal Pharmaceuticals, Inc.

Complete source-backed total liabilities history.

Historical Total Liabilities

Date	Total liabilities	Current liabilities	Accounts payable	Noncurrent debt	Other noncurrent liabilities
2026-06-30	—	$883.19M	—	$2.56B	—
2026-03-31	—	$728.05M	—	$2.57B	—
2025-12-31	—	$881.63M	—	$2.57B	—
2025-09-30	—	$862.11M	$266.36M	$2.57B	—
2025-06-30	—	$1.11B	$205.81M	$2.15B	—
2025-03-31	—	$1.08B	$192.53M	$2.15B	—
2024-12-31	—	$1.13B	$258.69M	$2.16B	—
2024-09-30	—	$1.1B	$235M	$2.17B	—
2024-06-30	—	$1.11B	$199.58M	$2.18B	—
2024-03-31	—	$834.39M	$175.33M	$2.38B	—
2023-12-31	—	$846.6M	$143.57M	$2.39B	—
2023-09-30	—	$760.6M	$177.4M	$2.54B	—
2023-06-30	—	$777.35M	$139.53M	$2.55B	—
2023-03-31	—	$703.71M	$136.92M	$2.56B	$41.46M
2022-12-31	—	$752.8M	$165.98M	$2.59B	$87.47M
2022-09-30	—	$818M	—	$2.61B	$78.26M
2022-06-30	—	$993.06M	—	$2.62B	$79.21M
2022-03-31	—	$602.04M	—	$2.67B	$32.87M
2021-12-31	—	$677.24M	$131.08M	$2.68B	$38.9M
2021-09-30	—	$667.34M	—	$2.69B	$60.8M
2021-06-30	—	$672.86M	—	$2.72B	$63.26M
2021-03-31	—	$636.78M	—	$2.73B	$63.79M
2020-12-31	—	$676.9M	$153.14M	$2.74B	$83.37M
2020-09-30	—	$667.89M	—	$2.76B	$96.19M
2020-06-30	—	$655.02M	—	$2.76B	$93.77M
2020-03-31	—	$965.07M	—	$2.77B	$80.85M
2019-12-31	—	$550.41M	$103.02M	$2.61B	$39.58M
2019-09-30	—	$534.91M	—	$2.61B	$38.53M
2019-06-30	—	$546.16M	—	$2.62B	$28.65M
2019-03-31	—	$599.53M	—	$2.63B	$37.72M
2018-12-31	—	$553.85M	$114.85M	$2.63B	$38.78M
2018-09-30	—	$749.27M	$124.54M	—	$44.77M
2018-06-30	—	$669.74M	$169.05M	$2.64B	$45.67M
2018-03-31	$0.00	$0.00	—	—	—
2017-12-31	$0.00	$296.88M	$70.01M	$1.36B	$7.79M